ca 549 , a new marker for breast cancer , was measured in serum of 719 patients by an immunoradiometric assay involving two monoclonal antibodies : bc4e 549 , developed against a breast-tumor cell line , and bc4n 154 , developed against milk fat-globule membrane .
C0006142
breast cancer
C0006141
breast